Navigation Links
Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement
Date:3/2/2011

BOSTON, March 2, 2011 /PRNewswire/ -- Joslin Diabetes Center has launched a groundbreaking initiative for primary care physicians to improve diabetes care. Joslin, with technology from Forward Health Group, Inc., is providing qualifying primary care practices in the United States with the critical capability to extract usefulness out of existing clinical data at the individual patient level, and to combine this information with practice improvement support and education. The initiative is supported via independent continuing medical education (CME) grant funding provided by GlaxoSmithKline and Merck & Co.

"To move the needle toward real improvement in diabetes, we need to know where the gaps are in order to provide targeted education and resources to improve," said Richard Beaser, M.D., Medical Executive Director for Joslin Professional Education. "This initiative does exactly that."

Using clinical informatics tools provided by Forward Health Group, Joslin is providing enhanced electronic clinical data capture and outcomes data visualization capabilities to qualifying practitioners.  Each practitioner is then directed to a suite of Joslin education, tools and resources targeted to individual gaps to support improvement over time well beyond the scope of the performance improvement (PI) CME activity alone.

"This initiative truly has the potential to be transformational," said Michael Barbouche, Founder/CEO of Forward Health Group. "The world's leading provider of clinical care, research and education in diabetes can now provide total population data for the busy primary care doctor.  Participating physicians can view their entire panel of patients, identify gaps in execution and delivery of care, and rely on Joslin education resources to improve. It's a great opportunity for practices to improve where they most need it and meet important quality benchmarks and certain CME and potentially Maintenance of Certification (MOC) requirements without having to invest many hours in manually abstracting charts."

In addition to data support, participating practices will have access to proven education and point of care tools and resources and other dedicated Joslin staff support.  Joslin is actively recruiting practices. Interested parties should contact Karen Kuc at 617-226-5933 or karen.kuc@joslin.harvard.edu.

About Joslin Diabetes Center and Joslin Professional EducationJoslin Diabetes Center is the world's preeminent diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent, nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, visit www.joslin.org.

Joslin Diabetes Center, accredited since 1995, was most recently awarded Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) in 2006.  Joslin's innovative performance improvement focused CME program for physicians and other health professionals advance the highest standards of care. The program includes live symposia and courses, Audio CD's, mobile applications, Web-based educational activities, and Performance Improvement CME Pathways. For more information about Joslin Professional Education and Joslin PI CME pathways visit www.jpec.joslin.org.

About Forward Health GroupForward Health Group is a leading-edge clinical informatics company, transforming fragmented clinical and administrative healthcare data stored in disparate systems, into actionable information that can be used to drive population health improvement. For more information, visit www.forwardhealthgroup.com.Contacts:Eric BenderSenior Communications Specialist, Joslin Diabetes Center617-309-2418 or eric.bender@joslin.harvard.edu .Barry WightmanVice President, Marketing, Forward Health Group, Inc.414 418 5654 or bmw@forwardhealthgroup.com
'/>"/>

SOURCE Forward Health Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
2. Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
3. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
4. Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
5. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
6. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
7. Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico
8. Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award
9. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
10. Use of Non-Traditional Providers in the Phoenix Market Will Improve Diabetes Prescription Drug Adherence
11. Reportlinker Adds Diabetes Market to 2016 - Biguanides and Insulin Analogs will be the Largest Selling Anti-Diabetic Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Visiomed, the French leader in ... is changing the landscape of healthcare with their ... pro-active, custom-made solutions. Recognizing the rising demand of ... healthcare without walls, Visiomed has launched BewellConnect, the ... healthcare professionals that is empowering the lives of ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... eine nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 ... Errichtung einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Thinksport, the most award-winning sunscreen on ... of Marin. For the second year in a row, cyclists will stay protected ... are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... Gorce Country Club in Miami Beach to host its Swirl: Miami Wine Tasting ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an approved content provider for the National Institute for Health and Care ... social care-related organizations in the National Health Service (NHS) to search, order and ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... interactive publication where generations converge and explore the world from different perspectives. By ... Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
Breaking Medicine News(10 mins):